Increasing generic drug use in medicare part D: The role of government

被引：23

作者：

Kohl, Herb

Shrank, William H. ^{[1
]}

机构：

[1] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02120 USA

[2] US Senate, US Senate Special Comm Aging, Washington, DC 20510 USA

来源：

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY | 2007年 / 55卷 / 07期

关键词：

D O I：

10.1111/j.1532-5415.2007.01286.x

中图分类号：

R592 [老年病学]; C [社会科学总论];

学科分类号：

03 ; 0303 ; 100203 ;

摘要：

[No abstract available]

引用

页码：1106 / 1109

页数：4

共 39 条

[1] Barriers to patient-physician communication about out-of-pocket costs [J].

Alexander, GC ;

Casalino, LP ;

Tseng, CW ;

McFadden, D ;

Meltzer, DO .

JOURNAL OF GENERAL INTERNAL MEDICINE, 2004, 19 (08) :856-860

[2] Patient-physician communication about out-of-pocket costs [J].

Alexander, GC ;

Casalino, LP ;

Meltzer, DO .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (07) :953-958

[3] Part "D" for "defective" - The Medicare drug benefit chaos. [J].

Avorn, J .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (13) :1339-1341

[4] A RANDOMIZED TRIAL OF A PROGRAM TO REDUCE THE USE OF PSYCHOACTIVE-DRUGS IN NURSING-HOMES [J].

AVORN, J ;

SOUMERAI, SB ;

EVERITT, DE ;

ROSSDEGNAN, D ;

BEERS, MH ;

SHERMAN, D ;

SALEMSCHATZ, SR ;

FIELDS, D .

NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (03) :168-173

[5]

*C BUDG OFF, BUDG EC OUTL FISC YE

[6] Should patients receive secondary prevention medications for free after a myocardial infarction? An economic analysis [J].

Choudhry, Niteesh K. ;

Avorn, Jerry ;

Antman, Elliott M. ;

Schneeweiss, Sebastian ;

Shrank, William H. .

HEALTH AFFAIRS, 2007, 26 (01) :186-194

[7]

COX E, 2006, 2005 GENERIC DRUG US

[8] A practical physicians' guide to the medicare drug benefit plan [J].

Federman, Alex D. ;

Alexander, G. Caleb ;

Shrank, William H. .

MAYO CLINIC PROCEEDINGS, 2006, 81 (09) :1217-1221

[9] Economic implications of evidence-based prescribing for hypertension - Can better care cost less? [J].

Fischer, MA ;

Avorn, J .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (15) :1850-1856

[10] Medicaid prior-authorization programs and the use of cyclooxygenase-2 inhibitors [J].

Fischer, MA ;

Schneeweiss, S ;

Avorn, J ;

Solomon, DH .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (21) :2187-2194

← 1 2 3 4 →